BA
CPXX

BlackRock Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

BlackRock Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-23,796
Closed -$718K – 3815
2016
Q2 		$718K Buy
23,796
+20,580
+640% +$418K ﹤0.01% 1920
2016
Q1 		$35K Buy
+3,216
New +$10.5K ﹤0.01% 3280

BlackRock Advisors's CPXX Position: Q3 2016 in Review

BlackRock Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 23,796 shares — an estimated $718K sold.

BlackRock Advisors first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $718K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • BlackRock Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • BlackRock Advisors sold 23,796 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $718K.
  • BlackRock Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
  • BlackRock Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $718K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on BlackRock Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.